<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"><identifier identifierType="DOI">10.18710/NUNHDF</identifier><creators><creator><creatorName nameType="Personal">Dierkes, Jutta</creatorName><givenName>Jutta</givenName><familyName>Dierkes</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0003-0663-877X</nameIdentifier><affiliation>University of Bergen</affiliation></creator></creators><titles><title>Replication data for: Cystatin C proteoforms in chronic kidney disease</title></titles><publisher>DataverseNO</publisher><publicationYear>2021</publicationYear><subjects><subject>Medicine, Health and Life Sciences</subject><subject schemeURI="https://www.ncbi.nlm.nih.gov/mesh/68055316" subjectScheme="MeSH">Cystatin C</subject><subject schemeURI="https://www.ncbi.nlm.nih.gov/mesh/68007674" subjectScheme="MeSH">Kidney Diseases</subject><subject schemeURI="http://purl.obolibrary.org/obo/PEFF_0001030" subjectScheme="Mass spectrometry ontology">Proteoform</subject><subject schemeURI="http://purl.obolibrary.org/obo/DOID_784" subjectScheme="Human Disease Ontology">chronic kidney disesase</subject></subjects><contributors><contributor contributorType="ContactPerson"><contributorName nameType="Personal">Dierkes, Jutta</contributorName><givenName>Jutta</givenName><familyName>Dierkes</familyName><affiliation>University of Bergen</affiliation></contributor><contributor contributorType="Producer"><contributorName nameType="Organizational">University of Bergen</contributorName></contributor><contributor contributorType="DataManager"><contributorName nameType="Personal">Dahl, Helene</contributorName><givenName>Helene</givenName><familyName>Dahl</familyName></contributor><contributor contributorType="DataCollector"><contributorName nameType="Personal">Sandnes, Kristina</contributorName><givenName>Kristina</givenName><familyName>Sandnes</familyName></contributor><contributor contributorType="DataCollector"><contributorName nameType="Personal">Welland, Natasha L.</contributorName><givenName>Natasha L.</givenName><familyName>Welland</familyName></contributor><contributor contributorType="DataCollector"><contributorName nameType="Personal">Andresen, Iselin</contributorName><givenName>Iselin</givenName><familyName>Andresen</familyName></contributor><contributor contributorType="Researcher"><contributorName nameType="Personal">Meyer, Klaus</contributorName><givenName>Klaus</givenName><familyName>Meyer</familyName></contributor><contributor contributorType="WorkPackageLeader"><contributorName nameType="Personal">Lysne, Vegard</contributorName><givenName>Vegard</givenName><familyName>Lysne</familyName></contributor><contributor contributorType="Researcher"><contributorName nameType="Personal">Marti, Hans-Peter</contributorName><givenName>Hans-Peter</givenName><familyName>Marti</familyName></contributor><contributor contributorType="ProjectLeader"><contributorName nameType="Personal">Dierkes, Jutta</contributorName><givenName>Jutta</givenName><familyName>Dierkes</familyName></contributor><contributor contributorType="Distributor"><contributorName nameType="Organizational">University of Bergen</contributorName><affiliation>University of Bergen</affiliation></contributor></contributors><dates><date dateType="Submitted">2021-04-24</date><date dateType="Updated">2023-09-28</date></dates><resourceType resourceTypeGeneral="Dataset">clinical data</resourceType><sizes><size>8344</size><size>602672</size><size>3805</size><size>867</size></sizes><formats><format>text/plain</format><format>image/tiff</format><format>text/plain</format><format>text/plain</format></formats><version>1.1</version><rightsList><rights rightsURI="info:eu-repo/semantics/openAccess"/><rights rightsURI="http://creativecommons.org/publicdomain/zero/1.0">CC0 1.0</rights></rightsList><descriptions><description descriptionType="Abstract">Supplementary dataset to 'Cystatin C proteoforms in chronic kidney disease'&#xd;
&#xd;
This is a cross-sectional study on cystatin C proteoforms in patients with chronic kidney disease. The study was done at the University of Bergen and Haukeland University Hospital, Bergen, Norway. &#xd;
In total, 157 patients with various degrees of chronic kidney disease were included, and proteoforms of cystatin C were measured with MALDI-TOF. This dataset contains supplementary information.</description><description descriptionType="Abstract">&lt;p>    &#xd;
&lt;p> ABSTRACT: &#xd;
&lt;p> Cystatin C, a cysteine protease inhibitor, is used as a biomarker of renal function. It offers several advantages compared to creatinine, and formulas for the estimation of the glomerular filtration rate based on cystatin C have been developed. Recently, several proteoforms of cystatin C have been discovered, including an intact protein with a hydroxylated proline at the N-terminus, and N-terminal truncated forms. There is little knowledge about the biological significance of these proteoforms. &#xd;
&lt;p> Methods: Cross-sectional study of patients with different stages of chronic renal disease (pre-dialysis n=53; hemodialysis n=51, renal transplant n=53). Measurement of cystatin C proteoforms by MALDI-TOF MS, assessment of medicine prescription using the first two levels of the Anatomical Therapeutic chemical system from patients’ records.&#xd;
&lt;p>Results: Patients receiving hemodialysis had the highest cystatin C concentrations, followed by pre-dialysis patients and patients with a renal transplant. In all groups, the most common proteoforms were native cystatin C and CysC 3Pro-OH while the truncated forms made up 28%. The distribution of the different proteoforms was largely independent of renal function and total cystatin C. However, the use of corticosteroids (ATC-L02) and immunosuppressants (ATC-H04) considerably impacted the distribution of proteoforms. &#xd;
&lt;p>Conclusion: The different proteoforms of cystatin C increased proportionally with total cystatin C in patients with chronic kidney disease. Prescription of corticosteroids and immunosuppressants had a significant effect on the distribution of proteoforms. The biological significance of these proteoforms remains to be determined.</description></descriptions><geoLocations><geoLocation><geoLocationPlace>University of Bergen, and Haukeland University Hospital</geoLocationPlace></geoLocation></geoLocations></resource>